BD (NYSE:BDX) is celebrating the 70th birthday of its major manufacturing facility in Utah, which the company said produces billions of molded components each year. Located in the town of Sandy just south of Salt Lake City, the site was founded in 1956 under Deseret Pharmaceuticals. BD acquired the plant in 1986, and today it’s home to a … [Read more...] about BD’s IV catheters plant in Utah marks 70 years
BD
BD launches new central venous catheter insertion device
BD (NYSE:BDX) today announced the commercial launch of its CentroVena One insertion system, a central venous catheter (CVC) insertion device. Franklin Lakes, New Jersey-based BD says it's the first all-in-one CVC insertion device on the market. It designed the device to simplify central line placement for clinicians and enhance patient safety. … [Read more...] about BD launches new central venous catheter insertion device
BD picks up CE mark for next-gen stent graft
BD (NYSE:BDX) announced today that it received CE mark approval for its Liverty TIPS stent graft system. Franklin Lakes, New Jersey-based BD designed the stent graft to expand treatment options for patients with cirrhosis and complications of portal hypertension. The next-generation, adjustable-diameter device marks the latest advancement for … [Read more...] about BD picks up CE mark for next-gen stent graft
BD picks up CE mark for Revello vascular covered stent
BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system. Franklin Lakes, New Jersey–based BD designed Revello to treat atherosclerotic lesions in the common and external iliac arteries. The next-generation endovascular solution combines the flexibility of a nitinol self-expanding stent with … [Read more...] about BD picks up CE mark for Revello vascular covered stent
BD completes enrollment in vascular covered stent study
BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study. AGILITY, an FDA investigational device exemption (IDE) study, evaluates the Revello vascular covered stent in patients with peripheral arterial disease (PAD). Franklin Lakes, New Jersey–based BD initiated the trial earlier … [Read more...] about BD completes enrollment in vascular covered stent study
BD enrolls first patient in Rotarex catheter registry
BD [WtwhTicker symbol="BDX"](NYSE: BDX)[/WtwhTicker] today announced the enrollment of the first patient in the XTRACT Registry for its Rotarex catheter system. The prospective, multi-center, single-arm, post-market registry evaluates Rotarex's real-world performance in treating patients with peripheral artery disease (PAD) lesions. Franklin … [Read more...] about BD enrolls first patient in Rotarex catheter registry
BD to invest $35M to expand Nebraska syringe manufacturing
BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe manufacturing. The company expects to add approximately 50 new jobs, expanding the manufacturing at its Columbus, Nebraska, facility. BD says it aims to increase the resiliency of the U.S. healthcare system through its latest syringe … [Read more...] about BD to invest $35M to expand Nebraska syringe manufacturing
BD to begin real-world atherectomy registry for PAD
BD [WtwhTicker symbol="BDX"](NYSE: BDX)[/WtwhTicker] announced today that it plans to initiate a patient data registry for its Rotarex atherectomy system. The registry aims to measure real-world outcomes for patients with peripheral artery disease (PAD). XTRACT, a multi-center, single-arm, post-market registry assesses Rotarex's clinical … [Read more...] about BD to begin real-world atherectomy registry for PAD
BD warns on esophagogastric balloon tamponade tubes after death
The FDA issued a notice highlighting a letter issued by BD and its C.R. Bard Urology and Critical Care subsidiary warning of new balloon device instructions. This warning follows one death associated with the device issue. BD sent affected customers a notice updating instructions for all lots of certain esophagogastric balloon tamponade tubes. … [Read more...] about BD warns on esophagogastric balloon tamponade tubes after death
BD warns on intravascular catheter
The FDA shared an alert that BD (NYSE: BDX) and its Bard subsidiary warned customers of an issue with certain intravascular catheters. BD recommended the removal of certain unused PowerPICC intravascular catheters from use or sale. In-use PowerPICC intravascular catheters also received updated instructions for use. Affected products include the … [Read more...] about BD warns on intravascular catheter
